Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease? (Q30150784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Neisseria lactamica

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Andrew R Gorringe

series ordinal

1

1 reference

7 June 2017

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

373-379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Impact of meningococcal C conjugate vaccine in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Vaccine prevention of meningococcal disease, coming soon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Experimental disease models for the assessment of meningococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Fuzzy species among recombinogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: apropos of 1400 children sampled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Human immunity to the meningococcus. I. The role of humoral antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Development of natural immunity to Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Carriage of Neisseria meningitidis and Neisseria lactamica in a school population during an epidemic period in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Carriage ofNeisseria meningitidisandNeisseria lactamicain northern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Genetic diversity and carriage dynamics of Neisseria lactamica in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Meningococcal molecular mimicry and the search for an ideal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Detection of antibodies to common antigens of pathogenic and commensal Neisseria species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

NadA, a novel vaccine candidate of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Vaccine potential of the Neisseria meningitidis 2086 lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

For discussion: live attenuated vaccines for group B meningococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Evaluation of cross-reactive antigens as determinants of cross-bactericidal activity in pathogenic and commensal Neisseria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Interspecific neisserial high molecular weight proteins able to induce natural immunity responses are strongly correlated with in vitro bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

In vitro induction of memory-driven responses against Neisseria meningitidis by priming with Neisseria lactamica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Neisseria lactamica protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Outer membrane protein vesicle vaccines for meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Alternative vaccine strategies to prevent serogroup B meningococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.373

21 January 2018

Identifiers

DOI

10.1586/14760584.4.3.373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16026250%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference